Posts

Posted on

Body and Mind Strengthens Board with Veteran Cannabis Executive

PR Newswire



Alexis Podesta adds a wealth of management and cannabis experience

VANCOUVER, BC, March 8, 2021 /PRNewswire/ – Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operator focused on limited license markets is please to report that Alexis Podesta, who was instrumental in California’s transition from medical to adult use cannabis, has been appointed as a director of the Company.

Alexis Podesta has served in senior roles in both the public and private sector. Known for her talent to skillfully navigate complex policy and political issues, her broad portfolio has included problem-solving on high-profile policies in both government and the corporate world. 

Alexis was entrusted by both Governor Gavin Newsom and Governor Edmund G. Brown, Jr. to manage the sprawling California Business, Consumer Services and Housing Agency. As Secretary of the Cabinet-level Agency, she directed its $4.75 billion budget and nearly 6,100 employees. Alexis oversaw twelve departments, boards, a commission, a panel and a council whose job is to license and regulate professionals and businesses in California to protect consumers; regulate businesses engaged in financial transactions; preserve, expand and fund safe and affordable housing opportunities; to provide solutions to address homelessness in California; to investigate and research earthquake related issues to advise on ways to reduce earthquake risk; and to protect the civil rights of all Californians from acts of hate violence and unlawful discrimination in employment, housing and public accommodations.

Additionally, the departments under the agency provided $1.9 billion in funding for affordable housing; made $3.5 billion annually in loans for first-time homebuyers; made $600 million annually in loans for affordable multi-family properties; and provided $650 million in assistance to local jurisdictions to combat homelessness. Additionally, the Department of Fair Employment and Housing filed more than 22,500 civil rights cases.

Prior to being appointed to lead the Agency, Alexis served as the Director of External and International Affairs for Governor Brown. She directed outreach, communication and partnerships with stakeholder groups, and provided key support for the Governor’s special projects. In addition, Alexis was the Governor’s lead representative on international affairs and served as Chief of Protocol.

Before joining the Brown Administration, Alexis worked for Pacific Gas & Electric in Government Affairs. Prior to joining that utility, she spent nearly a decade in Washington, D.C., working first as the Director of Scheduling for U.S. Senator Dianne Feinstein (D-California), and then as the Manager of Government Relations for The Walt Disney Company.

Most recently, Alexis was appointed by Governor Newsom to serve on the State Compensation Insurance Fund Board of Directors. Established in 1914 by the state legislature, the State Fund provides workers’ compensation insurance for approximately 110,000 policyholders and has nearly $21 billion in assets. 

“Alexis brings a wealth of board, management and cannabis experience to Body and Mind and we look forward to increasing the depth and experience of our board,” stated Michael Mills, CEO of Body and Mind. “This past quarter was transformative as the Company achieved record revenues. We continue to expand operations and construction is progressing well at the NMG Ohio production facility. I look forward to working with Alexis and our team to continue the growth of Body and Mind as a trusted cannabis brand.”

The Company has granted an aggregate of 1,250,000 stock options (the “Options“) in accordance with the Company’s stock option plan at an exercise price of CDN$ 0.68 per share for a term of five years expiring on March 6, 2026. The Options were granted to current directors and officers of the Company.

The Options are subject to vesting provisions such that 25% of the Options vest six (6) months from the date of grant, 25% of the Options vest twelve (12) months from the date of grant, 25% of the Options vest eighteen (18) months from the date of grant and 25% of the Options vest twenty-four (24) months from the date of grant.

About Body and Mind Inc.

BaM is an operations focused multi-state operator investing in high quality medical and recreational cannabis cultivation, production and retail. Our wholly owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses and holds cultivation and production licenses. BaM products include dried flower, edibles, oils and extracts as well as GPEN Gio cartridges. BaM cannabis strains have won numerous awards including the 2019 Las Vegas Weekly Bud Bracket, Las Vegas Hempfest Cup 2016, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup.

BaM continues to expand operations in Nevada, California, Arkansas and Ohio and is dedicated to increasing shareholder value by focusing resources on improving operational efficiencies, facility expansions, state licensing opportunities as well as mergers and acquisitions.

Please visit www.bodyandmind.com for more information.
Instagram: @bodyandmindBaM
Twitter: @bodyandmindBaM

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.


Safe Harbor Statement


Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as “forward-looking statements”. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.

Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.

Cision View original content:http://www.prnewswire.com/news-releases/body-and-mind-strengthens-board-with-veteran-cannabis-executive-301242332.html

SOURCE Body and Mind Inc.

Posted on

Everbridge Announces Private Offering of $275 Million Convertible Notes

Everbridge Announces Private Offering of $275 Million Convertible Notes

BURLINGTON, Mass.–(BUSINESS WIRE)–
Everbridge, Inc. (Nasdaq: EVBG) announced today that it intends to offer, subject to market and other conditions, $275.0 million aggregate principal amount of convertible senior notes due 2026 (the Notes) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Everbridge also expects to grant the initial purchasers a 13-day option to purchase up to an additional $50.0 million aggregate principal amount of Notes.

The Notes will be general unsecured obligations of Everbridge and will accrue interest payable semiannually in arrears. The Notes will be convertible into cash, shares of Everbridge’s common stock or a combination of cash and shares, at Everbridge’s election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of the pricing of the offering.

Everbridge expects to use a portion of the net proceeds from the offering of the Notes to repurchase for a combination of cash and shares of its common stock a portion of its outstanding 1.50% Convertible Senior Notes due 2022 (the 2022 notes) in privately negotiated transactions concurrently with the offering of the Notes and to pay the cost of the capped call transactions described below. The terms of any repurchases of the 2022 notes will depend on factors, including the market price of Everbridge’s common stock and the trading price of the 2022 notes at the time of such repurchases.

Everbridge expects to use the remainder of any net proceeds for working capital and other general corporate purposes, including potential additional repurchases and redemptions of its existing convertible notes, investments in sales and marketing in the United States and internationally and in research and development. One of Everbridge’s primary growth strategies continues to be to pursue opportunities to acquire businesses or pursue strategic investments in complementary businesses or technologies or for geographic expansion, and at any time, Everbridge is engaged in active discussions regarding such acquisition opportunities. Although Everbridge has not entered into definitive agreements or commitments with respect to any potential acquisitions at this time, if any such transactions are consummated, Everbridge may use a substantial portion of the proceeds from this offering to fund the purchase price thereof or to replenish its existing cash resources used for that purpose.

In connection with any repurchase of the 2022 notes, Everbridge expects that holders of the outstanding 2022 notes that have hedged their equity price risk with respect to the 2022 notes (the hedged holders) will, concurrently with the pricing of the Notes, unwind their hedge positions by buying its common stock and/or entering into or unwinding various derivative transactions with respect to its common stock. The amount of Everbridge’s common stock to be purchased by the hedged holders may be substantial in relation to the historic average daily trading volume of its common stock. This activity by the hedged holders may increase the effective conversion price of the Notes. In connection with any repurchase of the 2022 notes, Everbridge intends to amend the terms of the existing capped call transactions that it entered into when the 2022 notes were issued to permit the remaining options underlying such capped call transactions to remain outstanding until November 1, 2022, which is the maturity date for the 2022 notes, even if all or a portion of the 2022 notes are converted, repurchased or redeemed prior to such date.

In connection with the pricing of the Notes, Everbridge expects to enter into capped call transactions with one or more of the initial purchasers and/or their respective affiliates or other financial institutions (the option counterparties). The capped call transactions are expected generally to reduce potential dilution to Everbridge’s common stock upon any conversion of Notes and/or offset any cash payments Everbridge is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap. If the initial purchasers exercise their option to purchase additional Notes, Everbridge expects to enter into additional capped call transactions with the option counterparties.

In connection with establishing their initial hedges of the capped call transactions, Everbridge has been advised that the option counterparties or their respective affiliates expect to enter into various derivative transactions with respect to Everbridge’s common stock concurrently with or shortly after the pricing of the Notes and/or purchase shares of Everbridge’s common stock concurrently with or shortly after the pricing of the Notes. This activity could increase (or reduce the size of any decrease in) the market price of Everbridge’s common stock or the Notes at that time.

In addition, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Everbridge’s common stock and/or purchasing or selling Everbridge’s common stock or other securities of Everbridge in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so following any conversion of the Notes, any repurchase of the Notes by Everbridge on any fundamental change repurchase date or otherwise, or any redemption date, in each case, if Everbridge exercises the relevant election under the capped call transactions). This activity could also cause or avoid an increase or a decrease in the market price of Everbridge’s common stock or the Notes, which could affect a noteholder’s ability to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, it could affect the number of shares of common stock, if any, and value of the consideration that a noteholder will receive upon conversion of the Notes.

Further, to the extent the counterparties to the existing capped call transactions do not agree to amend the terms of those transactions to permit those transactions to remain outstanding, those counterparties may unwind various derivatives and/or purchase or sell Everbridge’s common stock or other securities of Everbridge in the secondary market concurrently and/or following the pricing of the Notes, which would affect the market price of Everbridge’s common stock and the Notes.

Neither the Notes, nor any shares of Everbridge common stock issuable upon conversion of the Notes, have been registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Notes, the common stock potentially issuable upon conversion of the Notes or any other securities, and will not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

About Everbridge

Everbridge, Inc. is a global software company that provides enterprise software applications that automate and accelerate organizations’ operational response to critical events in order to Keep People Safe and Businesses Running™.

Forward-Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 including, without limitation, statements regarding the terms of the offering of the Notes, whether Everbridge will enter into and the extent, and potential effects, of the capped call transactions and the repurchases of the 2022 notes, the amendments to the existing capped call transactions (or any termination or unwind thereof), if any, the potential dilution to Everbridge’s common stock and statements regarding Everbridge’s intentions regarding the use of proceeds from the offering. These forward-looking statements are based on the current expectations of the management of Everbridge as of the date of this press release and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause actual results of Everbridge to be materially different from those reflected in the forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include market risks, among others. These and other risks are discussed in Everbridge’s filings with the SEC, including, without limitation, Everbridge’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 26, 2021. Given these uncertainties, you should not place undue reliance on forward-looking statements, which speak only as of the date hereof. Everbridge is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

EVERBRIDGE CONTACTS:

Jeff Young

Media Relations

[email protected]

781-859-4116

Joshua Young

Investor Relations

[email protected]

781-236-3695

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Software Technology Data Management Security

MEDIA:

Logo
Logo
Posted on

Argo Blockchain Purchases Land in Texas with Access to Power Generation Rights

Argo Blockchain Purchases Land in Texas with Access to Power Generation Rights

LONDON–(BUSINESS WIRE)–
Argo Blockchain, a global leader in cryptocurrency mining (LSE: ARB), is pleased to provide a further update to its previously announced non-binding Letter of Intent with DPN LLC of New York, which set out the terms for Argo to acquire 320 acres of land in West Texas, USA. The Company has now completed the acquisition of DPN LLC and as a result, has acquired the land.

The acquisition of DPN LLC (by way of a merger with a wholly owned subsidiary of Argo) gives Argo access to up to 800-megawatts of electrical power, where Argo intends to build a new 200mw mining facility over the next 12 months.This facility will provide Argo with what it believes are some of the lowest electricity rates in the world, the majority of which is from renewable sources.

The consideration for the acquisition was an initial price of US$5M, satisfied by the issue and allotment to the shareholders of DPN LLC of 3,497,817 new ordinary shares in Argo, with up to a further US$12.5m in shares at a predetermined price being payable if certain contractual milestones related to the facility are fulfilled.

Peter Wall, Chief Executive of Argo Blockchain, said: “Argo’s purchase of land in Texas represents a significant milestone for the Company and is a cause for celebration. It not only gives us greater control over our mining operations but also the ability to meaningfully expand our mining capacity on a large scale. We now have access to some of what we believe is the cheapest renewable energy worldwide,in a location where innovation in new technologies is encouraged and incentivised.”

XMS Capital Partners, LLC acted as a financial advisor to Argo Blockchain in connection with the transaction.

Application will be made for the 3,497,817 new Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. Admission is expected to occur at 8:00 a.m. on 11 March 2021. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company.

Following Admission, the total number of Ordinary Shares in issue will be 368,361,690 and the total number of voting rights will therefore be 368,361,690. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA’s Disclosure and Transparency Rules.

Argo Blockchain plc is a global leader in cryptocurrency mining with one of the largest and most efficient operations powered by clean energy. The Company is headquartered in London, UK and its shares are listed on the Main Market of the London Stock Exchange under the ticker: ARB and on the OTCQX Best Market in the United States under the ticker: ARBKF.

argoblockchain.com

North America
Wachsman: [email protected]

Tel: +1-212-835-2511

Europe
Salamander Davoudi

[email protected]

Tel: +44 7957 549 906

Emma Valgimigli

[email protected]

Tel: +44 7727 180 873

KEYWORDS: Europe United States United Kingdom North America Texas

INDUSTRY KEYWORDS: Professional Services Utilities Technology Other Technology Alternative Energy Energy Finance

MEDIA:

Posted on

Digital Cash enables cryptocurrency in physical retail

PR Newswire

STOCKHOLM, March 8, 2021 /PRNewswire/ — Crunchfish has created its own cryptocurrency Crunchcoins in an official Ethereum blockchain based test network and integrated it with Crunchfish’s Digital Cash with the purpose to showcase cryptocurrency offline payments and interoperability in physical retail.

Digital Cash may be integrated with any of the current payment schemes – card, Real-Time Payment and closed-loop wallets – as well as the payment schemes of tomorrow – Central Bank Digital Currency (CBDC) and cryptocurrencies.

Crunchfish has created its own cryptocurrency Crunchcoins to experiment and showcase that the world’s cryptocurrencies may be used in physical retail by integrating Digital Cash in a digital offline wallet. Digital Cash is based on a patent-pending two-tier settlement architecture, first offline at the moment of payment followed by settlement online to move money between accounts. VISA has recently proposed this two-tier architecture for CBDC. The digital offline wallet manages an offline balance, which is locked at a corresponding virtual account at the bank or the payment service to guarantee that enough funds are available at the settlement online. The two-tier settlement architecture enables cryptocurrency with payment services interoperability, cross-scheme and cross-border, and that it may be used within retail in the world.

“Digital Cash with cryptocurrency enables offline payments and payment services interoperability. This creates the possibility for broad scale use of crypto within retail”, says Paul Cronholm, Crunchfish’s founder and CTO.
  

Cryptocurrency is a digital currency without any central regulating body where cryptographic methods are used to guarantee transactions with a distributed consensus by blockchains. Bitcoin and Ether from Ethereum are well known examples. Cryptocurrencies have often been used for speculative investments, which has made the exchange rates very volatile.

For more information, please contact:

Joachim Samuelsson, CEO of Crunchfish AB
+46 708 46 47 88
[email protected] 

Ulf Rogius Svensson, IR & Marketing Manager
+46 733 26 81 05
[email protected]

Västra Hamnen Corporate Finance AB is the Certified Adviser. Email: [email protected]. Telephone +46 40 200 250.

This information is information that Crunchfish AB is obliged to publish in accordance to the EU Market Abuse Regulation. The information was provided by the contact person above for publication on March 8, 2021.

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/crunchfish/r/digital-cash-enables-cryptocurrency-in-physical-retail,c3301990

The following files are available for download:


https://mb.cision.com/Main/14959/3301990/1383748.pdf

210308 – Digital Cash enables cryptocurrency in physical retail


https://news.cision.com/crunchfish/i/logo-text,c2885942

logo text


https://news.cision.com/crunchfish/i/payment-flower-shop,c2885943

Payment Flower Shop

 

Cision View original content:http://www.prnewswire.com/news-releases/digital-cash-enables-cryptocurrency-in-physical-retail-301242329.html

SOURCE Crunchfish

Posted on

Gilat Announces Filing of 2020 Annual Report

PETAH TIKVA, Israel, March 08, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announces that it has filed its Annual Report on Form 20-F containing audited consolidated financial statements for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission.

The annual report will be available on the Gilat website (www.gilat.com). Shareholders may receive a hard copy of the annual report free of charge upon request.

About Gilat

Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications. With 30 years of experience, we design and manufacture cutting-edge ground segment equipment, and provide comprehensive solutions and end-to-end services, powered by our innovative technology. Delivering high value competitive solutions, our portfolio comprises of a cloud based VSAT network platform, high-speed modems, high performance on-the-move antennas and high efficiency, high power Solid State Amplifiers (SSPA) and Block Upconverters (BUC).

Gilat’s comprehensive solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense and public safety, all while meeting the most stringent service level requirements. Gilat controlling shareholders are the FIMI Private Equity Funds. For more information, please visit: www.gilat.com

Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “estimate”, “project”, “intend”, “expect”, “believe” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of Gilat to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, risks associated with the outbreak and global spread of the coronavirus (COVID-19) pandemic; changes in general economic and business conditions, inability to maintain market acceptance to Gilat’s products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for Gilat’s products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company’s proprietary technology and risks associated with Gilat’s international operations and its location in Israel. For additional information regarding these and other risks and uncertainties associated with Gilat’s business, reference is made to Gilat’s reports filed from time to time with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements for any reason.

Contact:

Gilat Satellite Networks
Doreet Oren, Director Corporate Communications
[email protected]

GK Investor and Public Relations
Ehud Helft, Managing Partner
[email protected] 



Posted on

Cordia to Expand Cryptocurrency Initiatives

Adding Crypto Rewards and NFTs to virtual restaurants

LOS ANGELES, March 08, 2021 (GLOBE NEWSWIRE) — Cordia Corporation (OTC: CORG) today announced that it will expand its efforts to integrate cryptocurrency rewards into its upcoming virtual restaurants.

The company created what it believes to be the first cryptocurrency rewards program in the food delivery industry last year. Users of the Snackpass app had the opportunity to earn a popular cryptocurrency called MORE Coin (www.mre.live) as a reward for frequent ordering from the company’s virtual locations in Las Vegas.

Cordia saw an increase in business from cryptocurrency users at the outlet that awarded the MORE Coin to customers. The company also observed additional engagement on its social media channels and received direct inquiries regarding cryptocurrency and food delivery. The results even taking into account the effects of the pandemic were encouraging.

Based on the data received from the pilot program, the company is developing a proprietary crypto reward program to be used across all of its virtual brands. Diners will earn exclusive crypto rewards in the form of a digital token by patronizing Cordia virtual restaurants. Specific benefits, tier levels, and a potential crypto exchange listing for the token will be announced closer to the launch date.

In addition to reward points, Cordia expects to include celebrity and branded NFTs for specific virtual restaurants. Non-fungible tokens (NFTs) are unique digital goods is that cannot be replicated. Trading cards, short videos and artwork are anticipated to be included as part of the company’s initial NFT offerings in conjunction with the launch of its celebrity virtual restaurants.

“We are excited to expand our crypto incentive programs. We think that having a crypto rewards program will allow us to reach new audiences, give us a significant advantage in the food delivery industry, and provide real additional value to our network of restaurant partners and potential franchisees. Our NFTs will take the idea of a prize with your meal to another level given that they are digital and should be very collectible” added Peter Klamka, President of Cordia Corporation.

The company currently is developing virtual restaurants with Denise Richards, Carmen Electra, Busta Rhymes, and Holly Sonders. Cordia is in discussions with several world class athletes, notable entertainers, and video game titles for future app based restaurants.

Kate Ellis
[email protected]

This news release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities & Exchange Act of 1934, as amended, with respect to achieving corporate objectives, including developing a cryptocurrency reward program, concluding negotiations for additional virtual restaurants, creating collectible items the general public is interested in buying and developing virtual restaurants. The Company’s plans described above and otherwise are contingent upon adequate financing, of which there are no assurances. No information in this press release should be construed as any indication whatsoever of the Company’s future financial results, revenues or stock price. These statements are made under the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein. 



Posted on

Camping World Holdings Announces Expansion Plans in Delaware, Nebraska and Montana

Camping World Holdings Announces Expansion Plans in Delaware, Nebraska and Montana

Company Continues March to National Platform

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–
Camping World Holdings, Inc. (NYSE: CWH) (“Camping World”), America’s Recreation Dealer, today announced expansion plans in Delaware, Nebraska and Montana. The company owns or is in the process of acquiring land in these three states to support the continued march towards a national recreational dealer platform.

“We continue to fill in the missing pieces towards our goal of operating locations in the 48 contiguous states,” said Marcus Lemonis, CEO and Chairman of Camping World Holdings. “In certain states, where we are unable to find a dealership to acquire, we will build our own location.”

Plans are in various stages of development in the Georgetown, Delaware; Lincoln, Nebraska; and Billings, Montana markets. The new recreational dealer facilities will be the first for Camping World in each respective state.

Camping World Holdings, the nation’s largest network of RV and outdoor lifestyle centric locations, currently owns and operates over 170 SuperCenters nationwide and a comprehensive ecommerce platform, specializing in RV sales and service, RV parts and accessories, outdoor lifestyle products and its entire portfolio of Good Sam products and services. From new strategic acquisitions, new store development and facility upgrades, the Company’s network will continue to expand and evolve while serving its customers’ outdoor, RV and camping needs.

Camping World is always looking for seasoned and professional RV sales associates, technicians, and retail support to assist with locations across the country. Individuals interested in applying for a position may visit http://www.campingworldcareers.com/.

About Camping World Holdings, Inc.

Camping World Holdings, headquartered in Lincolnshire, Illinois, is America’s leading recreational vehicle and outdoor retailer, offering an extensive assortment of recreational vehicles for sale, RV and camping gear, RV maintenance and repair, other outdoor and active sports products, and the industry’s broadest and deepest range of services, protection plans, products and resources. Since the Company’s founding in 1966, Camping World has grown to become one of the most well-known destinations for everything RV, with more than 170 locations in 38 states and a comprehensive e-commerce platform. For more information, visit www.CampingWorld.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning Camping World and other matters. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Statements regarding our future development plans, expansions, acquisitions and new store openings are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘expects,’’ ‘‘plans,’’ ‘‘anticipates,’’ ‘‘could,’’ ‘‘intends,’’ ‘‘targets,’’ ‘‘projects,’’ ‘‘contemplates,’’ ‘‘believes,’’ ‘‘estimates,’’ ‘‘predicts,’’ ‘‘potential’’ or ‘‘continue’’ or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. You should carefully consider the risks and uncertainties that affect our business, including the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K filed for the year ended December 31, 2019, as updated in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and our other reports filed with the SEC. These forward-looking statements speak only as of the date of this communication. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our public announcements and filings with the Securities and Exchange Commission.

For Media Outlets:

Contact Karen Porter [email protected]

KEYWORDS: United States North America Delaware Illinois Nebraska Montana

INDUSTRY KEYWORDS: Other Retail General Automotive Vacation Specialty Other Consumer Women Seniors Other Sports Retail Men Family Consumer Online Retail Commercial Building & Real Estate Construction & Property Outdoors General Sports Other Automotive Other Travel General Entertainment Transportation Recreational Vehicles Lodging Destinations Travel Entertainment Automotive Sports

MEDIA:

Logo
Logo
Posted on

USPTO grants Lleida.net a new patent for its EIDAS notification method

– The EIDAS method is vital for companies wanting to communicate electronically following the European Single Market legislation.

– Lleida.net holds 203 patents worldwide on its eSignature and eNotification methods.

– The company was a top-performer in the European market in 2020, with a stock rise of over 940% during the year.

PR Newswire

MADRID, March 8, 2021 /PRNewswire/ — The United States Patent and Trademark Office has granted Spanish OTCQX-listed company Lleida.net its sixth patent, this time referring to its registered and qualified electronic notification method EIDAS, a key to communicating electronically within the European market. 

EIDAS is the European regulation that sets the rules in all matters relating to identification and trust services for electronic transactions within the EU.

This patent bears the name “Platform and method of certification of an electronic notice for electronic identification and trust services” (EIDAS).

The system, created by the company’s founder and CEO, Sisco Sapena, makes it possible to reliably identify the sender, the recipient and the data sent in electronic notifications. 

It guarantees reliable electronic communication within Europe and has been granted for 20 years.

The company was already a pioneer in securing European homologation for this method in 2018. 

The patent on the method, which Lleida.net distributes under the trade name Openum eIDAS, is valid for 20 years. 

The Openum EIDAS trademark itself was granted register last year by the United States Patent and Trademark Office (USPTO) for ten years.


LLEIDA.NET

 HOLDS
FIVE OTHER PATENTS IN THE UNITED STATES AND 203 WORLDWIDE

Lleida.net, which trades in New York since November 2020, had already received five other patents from the United States Patent and Trademark Office.

The most recent, granted last October, refers to the company’s method for certifying emails containing an electronic signature recognised by a telecommunications operator.

To date, Lleida.net has accumulated 203 patents from 64 countries worldwide.

Patents have been granted for its method for the registration and certification of receipt of electronic mail, its method for certifying the sending of electronic mail, its method for registering delivery of SMS/MMS data messages to mobile terminals, and its method for producing certified electronic contracts.

Among the nations and international organisations that have acknowledged  the company’s innovations are, in addition to the United States, the European Union and all its member states, China, Japan, Australia, New Zealand, the Gulf Cooperation Council, Israel, South Africa, Colombia or Mexico.

INTELLECTUAL PROPERTY IS KEY IN LLEIDA.NET’S STRATEGY
 

Intellectual property and innovation are part of the company’s strategic pillars, together with that of internationalisation and its commitment to Research and Development.

The purpose of having these patents is to protect the company’s market position within the registered electronic signature and notification industry and the investments of the more than 3,000 shareholders that form part of the company’s cap table. 

COMPANY HIGHLIGHTS

  • Lleida.net is the only company in the world traded in OTCQX (New York), Euronext Growth (Paris), and BME Growth (Madrid), at the same time, under the tickers (OTCQX: LLEIF), (BME: LLN), and (EPA: ALLLN).
  • It was founded in 1995 and is the leading European public company in the eSignature and eNotification industry. 
  • The company registered record sales of more than 19.57 million USD in 2020, 20 per cent more than in 2019.
  • This advance in the company’s turnover came as a direct consequence of the boom in its Software as a Service (SaaS) line during 2020, which grew 59 per cent YoY, to 6.78 million dollars.
  • The company’s stock rose 940% during 2020, in one of the best stock market performances in Europe.
  • According to official market data, the company’s market cap amounts to more than 3,000 shareholders. 24% of the company’s shares are in the hands of institutional investors.
  • Lleida.net’s founder, Sisco Sapena, controls 37.71% of the company. 

International Profile

  • The company has 19 offices worldwide. In the United States, its Head Office is in Miami. The company has other offices in the Americas, including Bogotá and Lima.
  • Lleida.net recently announced the incorporation of a new subsidiary in Dubai to be named Lleidanet SaaS services to engage the Middle East and African markets. 
  • More than half of its clients are international and come from outside Spain, its head market. 
  • The company is the official and sole supplier of SaaS eSignature and eNotification services to four national postal services, including those of the United Arab Emirates, Colombia and South Africa.
  • More than 75 countries recognise the legal validity of its electronic methods as a means of certifying legal notices in procurement processes.

FURTHER INFO

Investors can download the company’s Investment Deck at the following link: https://investors.lleida.net/docs/2020-estimated-results.pdf

Further information on the Openum EIDAS service can be obtained here: https://www.lleida.net/en/openum-eidas-qualified-delivery

The full list of patents granted to the company can be retrieved in the following link:
 
https://www.lleida.net/en/patents

Full information on the company’s investment proposition is available at http://investors.lleida.net 

Investors can contact Lleida.net’s team at [email protected].

The Paloma Project, Media, [email protected], +356 7946 7486

Cision View original content:http://www.prnewswire.com/news-releases/uspto-grants-lleidanet-a-new-patent-for-its-eidas-notification-method-301242321.html

SOURCE Lleida.net

Posted on

Hyzon Motors Announces “Hydrogen Now™” Event To Showcase Virtual Ride Along in a Zero-Emission, Hydrogen Fuel Cell Powered Truck at Hyzon’s Production-Ready Groningen Facility

PR Newswire

ROCHESTER, N.Y. and GRONINGEN, Netherlands, March 8, 2021 /PRNewswire/ — Hyzon Motors Inc. (“Hyzon” or “the Company”), a leading global supplier of zero-emission hydrogen fuel cell powered commercial vehicles, today announced that it will hold the “Hydrogen Now” livestreaming event, which will feature an online livestream of a virtual ride along in one of the Company’s hydrogen fuel cell powered trucks. The virtual ride along will stream live from Hyzon’s European facility in the Groningen area of the Netherlands. Opportunities for Q&A will follow for pre-registered members of the media.

As announced on February 9, 2021, Hyzon has entered into definitive agreement for a business combination with Decarbonization Plus Acquisition Corporation (NASDAQ: DCRB, DCRBW, DCRBU), a publicly-traded special purpose acquisition company (SPAC) that would result in Hyzon becoming a publicly listed company. Completion of the proposed transaction is subject to customary closing conditions, and is expected to occur in the second quarter of 2021.

Interested participants are invited to attend the virtual “Hydrogen Now” event to get a live look at the Hyzon fuel cell system, take a virtual seat behind the wheel, and go for a drive in a hydrogen fuel cell powered truck prior to its delivery to a local customer in Europe.


What:

Hyzon Motors “Hydrogen Now” event with Virtual Ride Along in a Hydrogen Fuel Cell Powered Truck


When: 

Wednesday, March 17, 2021, 9:00 a.m. to 9:20 a.m. US Eastern Standard Time


Where: 

The livestream can be accessed at: www.hyzonmotors.com/virtualdrive0321


Who: 

Hyzon executives will provide brief remarks ahead of the “Hydrogen Now” event and will be available to press for Q&A following the event. Media may request a virtual press pass from Hyzon’s US media contact.

Hyzon’s European operations were formed through a joint venture between Hyzon Motors and Holthausen Clean Technology B.V. to produce high quality, locally built, zero-emission commercial vehicles.

The Groningen facility is already assembling hydrogen fuel cell powered heavy vehicles, and Hyzon is taking orders for deliveries of Hyzon-branded commercial vehicles worldwide. In fact, Hyzon and Hiringa Energy (New Zealand) recently announced that the two companies had signed a vehicle supply agreement. Hyzon is targeting the delivery of 1,500 fuel cell powered heavy trucks by 2026 as part of the agreement with Hiringa. As binding orders for those trucks are placed, Hyzon anticipates fulfilling them from the Groningen facility, with first shipments planned for the second half of 2021.

About Hyzon Motors Inc.
Headquartered in Rochester, NY and with operations in Europe, Singapore, Australia and China, Hyzon is a leader in hydrogen mobility. Hyzon is led by co-founders George Gu, Craig Knight and Gary Robb and is a pure-play hydrogen mobility company with an exclusive focus on hydrogen in the commercial vehicle market. Utilizing its proven and proprietary hydrogen fuel cell technology, Hyzon aims to produce zero-emission heavy duty trucks and buses for customers in North America, Europe, and across the world. The company is contributing to the escalating adoption of hydrogen vehicles through its demonstrated technology advantage, leading fuel cell performance and history of rapid innovation. Visit www.hyzonmotors.com

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act. All statements, other than statements of present or historical fact included in this press release, including those regarding Decarbonization Plus Acquisition Corporation’s (“DCRB”) proposed acquisition of the Company and DCRB’s ability to consummate the transaction, are forward-looking statements. When used in this press release, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. Except as otherwise required by applicable law, DCRB and the Company disclaim any duty to update any forward looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release. DCRB and the Company caution you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of either DCRB or the Company, including risks and uncertainties described in the “Risk Factors” section of Exhibit 99.3 of DCRB’s Current Report on Form 8-K filed with the SEC on February 9, 2021 and other documents filed by DCRB from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Hyzon gives no assurance that Hyzon will achieve its expectations.

Hyzon Motors Contacts

For US, Europe and Asia Media:
Brian Brooks
H+K Strategies
713.858.8842
[email protected]

For Australian Media:
Fraser Beattie
Cannings Purple
[email protected]

For Investors:
Caldwell Bailey
ICR, Inc.
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/hyzon-motors-announces-hydrogen-now-event-to-showcase-virtual-ride-along-in-a-zero-emission-hydrogen-fuel-cell-powered-truck-at-hyzons-production-ready-groningen-facility-301242112.html

SOURCE HYZON Motors

Posted on

Aridis Enters into APEX™ Licensing and Product Discovery Agreement for Zoonotic Viruses with Kermode

PR Newswire

LOS GATOS, Calif., March 8, 2021 /PRNewswire/ — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced that it has entered into an out-licensing and product discovery agreement with Kermode Biotechnologies, Inc. Kermode works on vaccines and mAbs for zoonotic viruses, which are animal viruses that have the ability to infect humans.

Under the terms of the agreement, the activities of each party and the products discovered using Aridis’ APEXTM platform are structured as follow:

 

Kermode Biotechnologies

(Veterinary indications)

 

Aridis Pharma

(Human indications)

 
  • Kermode will fund for one year the discovery of product candidates for African Swine Fever Virus (ASFV) based on its novel treatment strategy, with an option for swine influenza virus (SIV)
  • Retains exclusive rights to mAbs and vaccines for veterinary uses discovered in the collaboration
  • Aridis to grant a non-exclusive license to APEX and apply the APEX technology platform to discover vaccines and mAbs to ASFV
  • Aridis exclusively retains rights to any products for human uses discovered in the collaboration

Aridis Leadership on the Licensing Agreement

“This agreement represents a continuation in Aridis’ expansion into the product discovery and development for viral pathogens, particularly those pathogens with pandemic potential. The licensing agreement with Kermode Biotechnologies presents another point of validation for our APEX antibody discovery platform,” said, Vu Truong, Ph.D., Chief Executive Officer of Aridis.

“As we have witnessed the global health and economic impact of the ongoing COVID-19 pandemic, it is critical we turn our attention towards other potential viruses that could reach pandemic levels. Given the potential for high morbidity and mortality associated with zoonotic viruses that cross over to the human population, we view this pivot as a natural segue for Aridis in our ongoing effort to stay ahead of emerging infectious diseases and protect the health of patients worldwide.”

Kermode Leadership on the Licensing Agreement

Dan Chen, Founder and CEO of Kermode, stated, “As we work to identify viable targets for both vaccine and therapeutic candidates for ASFV and SIV, we believe that by leveraging Aridis’ novel APEX discovery platform, we can reduce the time it takes to complete our discovery process and increase speed to market.

“Through our efforts, we seek to identify therapeutic solutions to the material impact that ASFV can have on the food sources for billions of people around the world, and avoiding the shocks to food supply that occurred in 2017. Concurrently, we recognize the possibility of zoonotic exposure of these viruses from animals to humans, which occurred with H1N1, H3N2 and H1N2 influenza viruses. 

“This collaboration is another step towards helping us solve some of these difficult challenges and are delighted to be partnering with Aridis on this licensing agreement.”

About APEXTM:  A potent monoclonal antibody pathogen discovery platform.

Aridis utilizes its APEX technology platform for the unbiased discovery of new and highly potent antibodies against pathogens, including COVID-19.



Rapid Pathogen Identification

The APEX platform is comprised of a silicon wafer-based array of nanoliter sized tissue micro-culture wells that enable rapid screening of antibody secreting cells, enabling discovery of potent antibodies against targets such as SARS-CoV-2, the virus that causes COVID-19 disease.

 



Higher Yield

APEX platform features CRISPR enabled activation of endogenous genetic control elements that dramatically increase the yield of such therapeutic antibodies from manufacturing production cell lines.

 



Shortened Manufacturing Cycle

APEX platform also features a proprietary production cell line that is designed to rapidly manufacture multiple monoclonal antibody therapeutics at faster the manufacturing cycle time than currently available manufacturing technologies.

 

About African Swine Fever Virus and Swine Influenza Virus

African Swine Fever Virus (ASFV) infects domestic pigs resulting in mortality rates close to 100%, with the onset of death occurring within several days. The virus is very stable in the environment and easily transmitted between animals through feedstocks, direct or indirect contact, and tick vectors. 

Once a region is infected with the virus it spreads very quickly, and the only available solution is to cull entire populations of swine. Swine populations in Europe, Russia, Africa and most recently China have all been affected by the virus and the economic toll has been devastating. There is currently no vaccine or treatment for ASFV in swine, and the probability of ASFV zoonosis to humans is low.

Swine Influenza Virus (SIV) consists of multiple strains of influenza virus including H1N1, H1N2, and others that are common in pigs worldwide. Transmission to humans is rare, primarily occurring to those who have regular exposure to pigs. In the rare event that swine influenza infects humans, the symptoms of ‘zoonotic’ swine flu in humans are influenza-like illness that largely resolves, but can be deadly in individuals with certain health preconditions. The most severe occurrence of human transmission was the 2009 swine flu pandemic where around 700 million to 1.4 billion people contracted the illness, which is more in absolute terms than the Spanish flu pandemic, resulting in approximately 284,000 possible fatalities worldwide. The most recent incidence of swine flu pandemic occurred in India in 2015, with over 31,156 positive test cases and 1,841 deaths. There is currently no approved vaccines or antibody treatments for SIV.

About Kermode Biotechnologies, Inc.

Kermode is a US-based, privately-held, biotechnology company focused on solving the challenges of animal health. Its immediate focus is on livestock viruses such as African Swine Fever Virus (ASFV) and Swine Influenza Flu (SIV).

Kermode is utilizing computational approaches to define vulnerable targets in structure, genetic composition and replication cycles of animal viruses. Once these targets are defined, Kermode applies state-of-the-art antibody discovery platforms to isolate therapeutic candidates with the highest potential to protect livestock against viral infections. This approach will allow Kermode to identify strong antibody therapeutics and construct vaccine candidates with long-lasting in vivo responses.

For additional information on Aridis Pharmaceuticals, please visit https://aridispharma.com/

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties.  These statements may be identified by the use of words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend” or other similar terms or expressions that concern Aridis’ expectations, strategy, plans or intentions. These forward-looking statements are based on Aridis’ current expectations and actual results could differ materially.  There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements.  These factors include, but are not limited to, the need for additional financing, the timing of regulatory submissions, Aridis’ ability to obtain and maintain regulatory approval of its existing product candidates and any other product candidates it may develop, approvals for clinical trials may be delayed or withheld by regulatory agencies, risks relating to the timing and costs of clinical trials, risks associated with obtaining funding from third parties, management and employee operations and execution risks, loss of key personnel, competition, risks related to market acceptance of products, intellectual property risks, risks related to business interruptions, including the outbreak of COVID-19 coronavirus, which could seriously harm our financial condition and increase our costs and expenses, risks associated with the uncertainty of future financial results, Aridis’ ability to attract collaborators and partners and risks associated with Aridis’ reliance on third party organizations.  While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described under the caption “Risk Factors” in Aridis’ 10-K for the year ended December 31, 2019 and Aridis’ other filings made with the Securities and Exchange Commission. Forward-looking statements included herein are made as of the date hereof, and Aridis does not undertake any obligation to update publicly such statements to reflect subsequent events or circumstances.

Contact:

Investor Relations
Dave Gentry, CEO
RedChip Companies
[email protected]
1-407-491-4498

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/aridis-enters-into-apex-licensing-and-product-discovery-agreement-for-zoonotic-viruses-with-kermode-301242303.html

SOURCE Aridis Pharmaceuticals, Inc.